{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:33:27Z","timestamp":1790555607626,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.reumae.2022.11.001","type":"journal-article","created":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T06:03:38Z","timestamp":1672725818000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Development of a web tool to calculate the cumulative dose of glucocorticoids"],"prefix":"10.1016","volume":"19","author":[{"given":"Nuria","family":"Montero-Pastor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas T.","family":"S\u00e1nchez-Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Guerra-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"S\u00e1nchez-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Moriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Loricera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"D\u00edaz-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reumae.2022.11.001_bib0110","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0168-8278(03)00428-8","article-title":"Immunosuppressive therapy in liver transplantation","volume":"39","author":"Conti","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.reumae.2022.11.001_bib0115","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","article-title":"The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights","volume":"335","author":"Coutinho","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.reumae.2022.11.001_bib0120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.rdc.2015.08.008","article-title":"Corticosteroids in lupus nephritis and central nervous system lupus","volume":"42","author":"Kamen","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.reumae.2022.11.001_bib0125","first-page":"1","article-title":"Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial","author":"Mathian","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2022.11.001_bib0130","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/02770903.2019.1708095","article-title":"Clinical characteristics and burden of illness among adolescent and adult patients with severe asthma by asthma control: the IDEAL study","volume":"58","author":"M\u00fcllerov\u00e1","year":"2021","journal-title":"J Asthma"},{"key":"10.1016\/j.reumae.2022.11.001_bib0135","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1517\/14740338.2016.1140743","article-title":"Long-term side effects of glucocorticoids","volume":"15","author":"Oray","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.reumae.2022.11.001_bib0140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/BOR.0b013e3282f51031","article-title":"The epidemiology of glucocorticoid-associated adverse events","volume":"20","author":"McDonough","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.reumae.2022.11.001_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1710-1492-9-30","article-title":"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"Suppl. 2","key":"10.1016\/j.reumae.2022.11.001_bib0150","article-title":"The value of glucocorticoid co-therapy in different rheumatic diseases \u2013 positive and adverse effects","volume":"16","author":"van der Goes","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.reumae.2022.11.001_bib0155","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s40744-019-00180-9","article-title":"Risk of potential glucocorticoid-related adverse events in patients with giant cell arteritis: results from a USA-based electronic health records database","volume":"6","author":"Best","year":"2019","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.reumae.2022.11.001_bib0160","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40744-018-0112-8","article-title":"Risk associated with cumulative oral glucocorticoid use in patients with giant cell arteritis in real-world databases from the USA and UK","volume":"5","author":"Gale","year":"2018","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.reumae.2022.11.001_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40360-016-0111-8","article-title":"Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids","volume":"18","author":"Parente","year":"2017","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.reumae.2022.11.001_bib0170","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/art.38210","article-title":"Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis","volume":"66","author":"Del Rinc\u00f3n","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.reumae.2022.11.001_bib0175","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/qjmed\/hci029","article-title":"A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids","volume":"98","author":"Van Staa","year":"2005","journal-title":"QJM"},{"key":"10.1016\/j.reumae.2022.11.001_bib0180","doi-asserted-by":"crossref","DOI":"10.1007\/s11657-018-0424-x","article-title":"Impact of cumulative exposure to high-dose oral glucocorticoids on fracture risk in Denmark: a population-based case\u2013control study","volume":"13","author":"Amiche","year":"2018","journal-title":"Arch Osteoporos"},{"key":"10.1016\/j.reumae.2022.11.001_bib0185","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/jbmr.3523","article-title":"Glucocorticoid exposure and fracture risk in a cohort of US patients with selected conditions","volume":"33","author":"Balasubramanian","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.reumae.2022.11.001_bib0190","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1136\/annrheumdis-2011-200702","article-title":"Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case\u2013control analysis","volume":"71","author":"Dixon","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2022.11.001_bib0195","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00256-019-03362-2","article-title":"Effects of intra-articular corticosteroid injections on lumbar trabecular density","volume":"49","author":"Florance","year":"2020","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.reumae.2022.11.001_bib0200","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1210\/jc.2019-00153","article-title":"Dose dependency of iatrogenic glucocorticoid excess and adrenal insufficiency and mortality: a cohort study in England","volume":"104","author":"Mebrahtu","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.reumae.2022.11.001_bib0205","first-page":"1262","article-title":"Oral corticosteroid use during pregnancy and risk of preterm birth","volume":"59","author":"Palmsten","year":"2020","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.reumae.2022.11.001_bib0210","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1002\/art.39682","article-title":"Cumulative corticosteroid dose over fifty-two weeks in patients with systemic lupus erythematosus: pooled analyses from the phase III belimumab trials","volume":"68","author":"van Vollenhoven","year":"2016","journal-title":"Arthritis Rheumatol"}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574322001782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574322001782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:03:09Z","timestamp":1761879789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173574322001782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2173574322001782"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2022.11.001","relation":{},"ISSN":["2173-5743"],"issn-type":[{"value":"2173-5743","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a web tool to calculate the cumulative dose of glucocorticoids","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2022.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2022.04.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights reserved.","name":"copyright","label":"Copyright"}]}}